| ²é¿´: 447 | »Ø¸´: 0 | |||
TAINSTÌú³æ (ÕýʽдÊÖ)
|
[½»Á÷]
±íÕ÷¶à¾§Ð͵Äת±ä
|
| Many drugs are formulated as solids. Although convenient and compact, solid drug formulations can be problematic because the active pharmaceutical ingredient can exist in more than one thermodynamically or kinetically stable crystalline or amorphous form, and can interconvert between these forms during processing or storage. The ability of a compound to exist in different solid state forms (polymorphism) impacts the solubility, and thus the bioavailability, of the pharmaceutical. Interconversion from a more soluble to a less soluble form may occur during manufacture of the pure drug, during formulation processes, and after long-term storage, thereby changing the pharmaceutically-active properties of the final product. |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ±íÕ÷¶à¾§ÐεÄת±ä.pdf
2016-07-04 16:19:44, 359.23 K
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼±
ÒѾÓÐ3È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ5È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ7È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ8È˻ظ´
ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ3È˻ظ´
ÈËÆø²»ÐÐÁË
ÒѾÓÐ10È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ10È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ24È˻ظ´
filecode£¬4¸öjtjcÁË
ÒѾÓÐ17È˻ظ´









»Ø¸´´ËÂ¥